Atlas Venture Life Science Advisors, LLC Ikena Oncology, Inc. Transaction History
Atlas Venture Life Science Advisors, LLC
- $751 Million
- Q2 2024
A detailed history of Atlas Venture Life Science Advisors, LLC transactions in Ikena Oncology, Inc. stock. As of the latest transaction made, Atlas Venture Life Science Advisors, LLC holds 5,018,178 shares of IKNA stock, worth $8.53 Million. This represents 1.1% of its overall portfolio holdings.
Number of Shares
5,018,178
Previous 5,018,178
-0.0%
Holding current value
$8.53 Million
Previous $7.13 Million
16.2%
% of portfolio
1.1%
Previous 0.89%
Shares
1 transactions
Others Institutions Holding IKNA
# of Institutions
72Shares Held
31.4MCall Options Held
0Put Options Held
0-
Bvf Inc San Francisco, CA4.77MShares$8.11 Million0.24% of portfolio
-
Blue Owl Capital Holdings LP New York, NY4.09MShares$6.95 Million2.8% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.54MShares$6.02 Million0.14% of portfolio
-
Omega Fund Management, LLC Boston, MA2.25MShares$3.82 Million4.84% of portfolio
-
Chi Advisors LLC New York, NY2.18MShares$3.71 Million4.65% of portfolio
About Ikena Oncology, Inc.
- Ticker IKNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,257,500
- Market Cap $61.6M
- Description
- Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. I...